Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
39%
upside
19 price targets
|
0
%
|
|
|
|
39%
upside
9 price targets
|
0
%
|
|
|
|
39%
upside
6 price targets
|
0
%
|
|
|
404
Cogent Biosciences
COGT
$5.69B
|
39%
upside
5 price targets
|
0
%
|
|
|
39%
upside
8 price targets
|
0
%
|
|
|
|
39%
upside
3 price targets
|
0
%
|
|
|
|
39%
upside
5 price targets
|
0
%
|
|
|
|
39%
upside
9 price targets
|
0
%
|
|
|
|
39%
upside
7 price targets
|
0
%
|
|
|
|
39%
upside
6 price targets
|
0
%
|
|
|
411
CG Oncology
CGON
$4.16B
|
39%
upside
4 price targets
|
0
%
|
|
|
38%
upside
3 price targets
|
0
%
|
|
|
|
38%
upside
3 price targets
|
0
%
|
|
|
|
38%
upside
5 price targets
|
0
%
|
|
|
|
38%
upside
5 price targets
|
0
%
|
|
|
|
38%
upside
6 price targets
|
0
%
|
|
|
|
38%
upside
6 price targets
|
0
%
|
|
|
|
38%
upside
3 price targets
|
0
%
|
|
|
|
37%
upside
14 price targets
|
0
%
|
|
|
|
37%
upside
5 price targets
|
0
%
|
|
|
|
37%
upside
6 price targets
|
0
%
|
|
|
|
37%
upside
4 price targets
|
0
%
|
|
|
|
37%
upside
7 price targets
|
0
%
|
|
|
|
37%
upside
3 price targets
|
0
%
|
|
|
|
37%
upside
3 price targets
|
0
%
|
|